Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-28Clinical Trial Results: Exercise and Vascular Function in Postmenopausal Females With Hypertension [NA]
A completed trial evaluating the effects of exercise on vascular function in postmenopausal females with hypertension. Results have been pos…
-
CLINICAL_TRIALS trial_result · 2026-08-27Clinical Trial Update: A Study to Evaluate the Efficacy and Safety in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension [Phase 3]
Phase 3 trial evaluating efficacy and safety in participants with uncontrolled hypertension on two or more medications, including resistant …
-
CLINICAL_TRIALS trial_result · 2026-08-20Clinical Trial Results: Timing of Sodium Intake and Nocturnal Sodium Excretion and Blood Pressure in Obese African Americans [NA]
A completed clinical trial evaluating how timing of sodium intake affects nocturnal sodium excretion and blood pressure in obese African Ame…
-
EMA approval · 2026-08-04EMA Authorised: Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop) (irbesartan;hydrochlorothiazide) — sanofi-aventis groupe
Authorised fixed-dose combination of irbesartan and hydrochlorothiazide for hypertension in the EU.
-
CLINICAL_TRIALS trial_result · 2026-07-31Clinical Trial Results: Improving Hypertension Medication Adherence for Older Adults [NA]
A completed clinical trial from the University of Arizona examining strategies to improve adherence to hypertension medications in older adu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-07-30Clinical Trial Results: A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension [Phase 3]
Phase 3 trial results evaluating Baxdrostat for uncontrolled hypertension on multiple medications, including resistant hypertension; results…
-
EMA approval · 2026-07-27EMA Authorised: Irbesartan Zentiva (previously Irbesartan Winthrop) (irbesartan) — Zentiva k.s.
The EMA has authorised Irbesartan Zentiva, a Reformulated/renamed irbesartan product for hypertension, under Zentiva k.s. as the marketing a…
-
EMA approval · 2026-07-27EMA Authorised: Macitentan AccordPharma (macitentan) — Accord Healthcare
Macitentan AccordPharma has been authorized for use, with the therapeutic areas listed as hypertension and pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2026-07-24Clinical Trial Results: A Study of Cardiovascular Disparities in the Greater Mankato Somali Community to Prevent Hypertension [NA]
A completed clinical trial studying cardiovascular disparities in the Greater Mankato Somali community to prevent hypertension; results post…
-
CLINICAL_TRIALS trial_result · 2026-07-23Clinical Trial Results: Validation of a Novel Non-invasive Continuous Blood Pressure Monitor in Children Ages 2- 17 Years-old [NA]
A completed clinical trial evaluating a novel non-invasive continuous blood pressure monitor in children aged 2-17 years with posted results…
-
EMA approval · 2026-07-21EMA Authorised: Tolucombi (telmisartan;hydrochlorothiazide) — Krka, d.d., Novo mesto
Authorised combination medicine Tolucombi (telmisartan and hydrochlorothiazide) for hypertension by Krka, d.d., Novo mesto.
-
CLINICAL_TRIALS trial_result · 2026-07-20Clinical Trial Results: Tailored Drug Titration Using Artificial Intelligence [NA]
Clinical trial results on tailored drug titration for hypertension using artificial intelligence have been completed and results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-15Clinical Trial Results: Social Risk Score, Clinical Decision Support Tool and Closed Loop Referral for Social Risk Screen and Referral [NA]
Completed clinical trial evaluating a social risk score, a clinical decision support tool, and closed-loop referral for social risk screenin…
-
EMA approval · 2026-07-08EMA Authorised: Tolura (telmisartan) — Krka, d.d., Novo mesto
Tolura (telmisartan) has been authorised in the EU for hypertension by Krka, d.d., Novo mesto.
-
CLINICAL_TRIALS trial_result · 2026-07-08Clinical Trial Results: Supporting Self-Management of Healthy Behaviors in Diabetes, Kidney Disease, and Hypertension [NA]
Completed clinical trial assessing self-management support for healthy behaviors in diabetes, kidney disease, and hypertension.
-
EMA approval · 2026-07-07EMA Authorised: Telmisartan Actavis (telmisartan) — Actavis Group PTC ehf
Telmisartan Actavis has been authorised for the treatment of hypertension in the EU.
-
CLINICAL_TRIALS trial_result · 2026-07-07Clinical Trial Results: CARDIA-Salt Sensitivity of Blood Pressure (SSBP) [NA]
Completed clinical trial assessing salt sensitivity of blood pressure; results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-30Clinical Trial Results: Addressing Antihypertensive Medication Adherence Through EHR-enabled Teamlets in Primary Care [NA]
A completed clinical trial evaluating EHR-enabled teamlets to improve antihypertensive medication adherence in primary care.
-
CLINICAL_TRIALS trial_result · 2026-06-29Clinical Trial Results: VicorderCS NIBP Validation Study to Review The Ability to Capture Blood Pressure Measurements
A completed clinical trial evaluating VicorderCS NIBP validation for accurately capturing blood pressure measurements.
-
CLINICAL_TRIALS trial_result · 2026-06-16Clinical Trial Results: Sleep and Circadian Mechanisms of Non-dipping Blood Pressure
Completed clinical trial on sleep and circadian mechanisms of non-dipping blood pressure; results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-15Clinical Trial Results: Improving Blood Pressure Control Among Food Insecure Hypertensive Adults [NA]
Completed clinical trial investigating strategies to improve blood pressure control among food insecure adults with hypertension; results po…
-
EMA approval · 2026-06-12EMA Authorised: Amlodipine / Valsartan Mylan (amlodipine besilate;valsartan) — Mylan Pharmaceuticals Limited
Amlodipine besilate/valsartan combination (Amlodipine besilate; valsartan) by Mylan Pharmaceuticals Limited has been authorised for hyperte…
-
EMA approval · 2026-06-11EMA Authorised: Winrevair — Merck Sharp & Dohme B.V.
Winrevair has been authorised by EMA, with therapeutic area listed as Hypertension and Pulmonary; orphan medicine designation.
-
CLINICAL_TRIALS trial_result · 2026-06-10Clinical Trial Results: Bridging the Evidence-to-practice Gap [Phase 4]
Phase 4 clinical trial results addressing hypertension to bridge evidence-to-practice gaps.
-
CLINICAL_TRIALS trial_result · 2026-06-02Clinical Trial Results: The Impact of a Resistance Training Intervention on Blood Pressure Control in Older Adults With Sarcopenia [NA]
Clinical trial results evaluating how a resistance training program affects blood pressure control in older adults with sarcopenia.